Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards - Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an

ADVERTISEMENT

Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards
Vaccine development holds the greatest promise and the greatest challenge for protecting the worldwide population from an avian flu pandemic


BioPharm International
Volume 19, Issue 2

8. Slater (2004), "Industry and Government Perspective in Influenza Control," Texas Heart Inst. J. 31:42-44.

9. Coyle (2005), "Consumer Groups Slam Vaccine Bill," National Law Journal Dec. 13, 2005.

10. Trivalent influenza vaccines were added to the VICP in July 2005, see http://www.hrsa.gov/osp/vicp/

11. See Coyle (2005), supra.

12. Section 6 of S. 1878, the Biodefense and Pandemic Vaccine and Drug Development Act of 2005.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here